Cargando…
Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment
OBJECTIVE: To assess intensive care unit (ICU) complications, their management, and prognostic factors associated with outcomes in a cohort of patients with autoimmune encephalitis (AE). METHODS: This study was an observational multicenter registry of consecutively included patients diagnosed with A...
Autores principales: | Schubert, Julia, Brämer, Dirk, Huttner, Hagen B., Gerner, Stefan T., Fuhrer, Hannah, Melzer, Nico, Dik, Andre, Prüss, Harald, Ly, Lam-Than, Fuchs, Kornelius, Leypoldt, Frank, Nissen, Gunnar, Schirotzek, Ingo, Dohmen, Christian, Bösel, Julian, Lewerenz, Jan, Thaler, Franziska, Kraft, Andrea, Juranek, Aleksandra, Ringelstein, Marius, Sühs, Kurt-Wolfram, Urbanek, Christian, Scherag, André, Geis, Christian, Witte, Otto W., Günther, Albrecht |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278855/ https://www.ncbi.nlm.nih.gov/pubmed/30568992 http://dx.doi.org/10.1212/NXI.0000000000000514 |
Ejemplares similares
-
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry
por: Thaler, Franziska S., et al.
Publicado: (2021) -
Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis
por: Wickel, Jonathan, et al.
Publicado: (2020) -
Seizure Semiology in Antibody-Associated Autoimmune Encephalitis
por: Kaaden, Tillman, et al.
Publicado: (2022) -
CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021) -
Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation
por: Stetefeld, Henning R., et al.
Publicado: (2021)